Morgan Lewis

Related Publications

01/09/13 FDA Releases Major New Food Safety Proposals
Affected parties should familiarize themselves with proposed rules for safe food processing and handling and on-farm produce safety; comments to FDA are due by May 16.
View all publications

Related Events

09/17/13-09/18/13 ACI's FDA Boot Camp
FDA partner Gary Yingling, speaker
10/03/13-10/04/13 U.S. FDA Drug Development and Compliance (CfPA)
FDA partner Gary Yingling, speaker
View all events

Related News

09/12/12 Morgan Lewis Lures Food And Drug Team From K&L Gates
Morgan Lewis's addition of a five-partner food, drug and medical device regulatory team to its Washington office is discussed.
09/05/12 Morgan Lewis Grows FDA & Healthcare Practice with Five-Partner Food and Drug Team
Morgan Lewis announces that a team of five well-recognized FDA regulatory lawyers have joined the firm as partners in its FDA and Healthcare Practice, resident in Washington, D.C.
View all news
Photo of  Gary L. Yingling

practice accolades

FDA & Healthcare

Ranked the second-largest U.S. healthcare law firm by Modern Healthcare (2012)

Recognized as a top 10 law firm within the Life Sciences Regulatory Super League by The Practical Law Company (PLC) (2012)

Listed as Recommended in PLC's Life Sciences Multi-Jurisdictional Guide (2012)

honors + affiliations

Past Chair, UNC Pharmacy Foundation

Adjunct Professor, The University of Florida College of Pharmacy

Listed, Life Sciences Star, LMG Life Sciences (2012)

Listed, Chambers USA, Healthcare: Pharmaceutical/Medical Products Regulatory (2012–2013)

Listed, Best Lawyers, FDA Law (2012)

Listed, Super Lawyers

Listed, Washington, D.C. Super Lawyers for FDA (2013)

Recipient, ACRP Global Conference Top Speaker Award (2012)

Recipient, FDLI's Distinguished Service and Leadership Award (1998)

Member, American Society for Pharmacy Law

Member, Association of Food and Drug Officials

Member, District of Columbia Bar Association

Member, Drug Information Association

Member, Federal Bar Association

Member, Regulatory Affairs Professionals Society

International Society for Regulatory Toxicology and Pharmacology

Former Chair, Scholarship Committee of the Food and Drug Law Institute

Editorial Board, Clinical Research Practices and Drug Regulatory Affairs Journal, the Regulatory Toxicology and Pharmacology Journal, the Biomedical and Environmental Sciences Journal, and the FDA Enforcement Manual

Past President, University of North Carolina School of Pharmacy Alumni Association

Review Board Member, U.S. Adopted Names Council

bar admissions

  • District of Columbia

Court Admissions

  • U.S. Supreme Court
  • U.S. District Court for the District of Columbia
print profile

Gary L. Yingling
Partner


Email: gyingling@morganlewis.com
Washington, D.C.
1111 Pennsylvania Ave., NW
Washington, DC 20004-2541
Phone: 202.739.5610
Fax: 202.739.3001

Gary L. Yingling is a partner in Morgan Lewis's FDA Practice. Mr. Yingling focuses his practice on issues involving the U.S. Food and Drug Administration (FDA) and has also represented clients in matters involving the U.S. Department of Agriculture Food Safety and Inspection Service, the Environmental Protection Agency, the Consumer Product Safety Commission, the Federal Trade Commission, and various states. His clients have included individuals, partnerships, and corporations in cases involving labeling, importation, regulatory marketing strategy, recalls, seizures, and criminal matters.

Mr. Yingling's work in the food industry involves a variety of matters, including ingredient safety questions and product labeling, and his work in the drug industry ranges from the preparation of Investigational New Drug (IND) applications to product labeling. He also has a particular interest in clinical research, contract research organization, and sponsor matters.

Prior to joining Morgan Lewis, Mr. Yingling was a partner in multiple food and drug practices of international law firms, resident in Washington, D.C. Before entering private practice, he served as president of the Food and Drug Law Institute for nine years. Earlier in his career, Mr. Yingling served in the FDA's office of the general counsel for 10 years, first as a trial attorney and later as associate chief counsel for its Bureau of Veterinary Medicine and as the deputy chief counsel for administration. He was also director of the Over-the-Counter (OTC) Drug Review in the Bureau of Drugs for two years. Mr. Yingling received the FDA's Award of Merit, the agency's highest award, in 1974 for his legal and administrative work on the OTC Review.

Mr. Yingling earned his J.D. from Emory University School of Law in 1968. Prior to attending law school, he practiced community pharmacy and is a registered pharmacist in Maryland and the District of Columbia. He earned his M.S. from Purdue University in 1966 and his B.S. from the University of North Carolina in 1962.

Mr. Yingling is admitted to practice in the District of Columbia and before the U.S. Supreme Court and the U.S. District Court for the District of Columbia.

education

  • Emory University School of Law, 1968, J.D.
  • Purdue University, 1966, M.S.
  • University of North Carolina, 1962, B.S.